Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Receivables - Net: 2019-2025

Historic Receivables - Net for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2025 value amounting to $25.8 million.

  • Burning Rock Biotech's Receivables - Net rose 8.85% to $25.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 8.85%. This contributed to the annual value of $27.1 million for FY2024, which is 16.47% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Receivables - Net of $25.8 million as of Q3 2025, which was down 83.81% from $159.5 million recorded in Q1 2025.
  • Burning Rock Biotech's Receivables - Net's 5-year high stood at $159.5 million during Q1 2025, with a 5-year trough of $11.6 million in Q1 2021.
  • Moreover, its 3-year median value for Receivables - Net was $26.5 million (2024), whereas its average is $70.9 million.
  • Per our database at Business Quant, Burning Rock Biotech's Receivables - Net soared by 850.85% in 2023 and then crashed by 85.25% in 2024.
  • Burning Rock Biotech's Receivables - Net (Quarterly) stood at $20.6 million in 2021, then rose by 7.52% to $22.2 million in 2022, then grew by 5.02% to $23.3 million in 2023, then climbed by 16.47% to $27.1 million in 2024, then grew by 8.85% to $25.8 million in 2025.
  • Its Receivables - Net stands at $25.8 million for Q3 2025, versus $159.5 million for Q1 2025 and $27.1 million for Q4 2024.